Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CRF antagonists in development at Novartis

Sep. 2, 1999

Cerebrus presents new NMDA receptor antagonists with selectivity for cerebellum

Sep. 1, 1999

MS&D's new GABA-A receptor ligands expected to be effective and safe for anxiety, etc.

Sep. 1, 1999

Dual M2 antagonism/AChE inhibition: an effective approach to treating memory disorders

Sep. 1, 1999

New glycine antagonist added to Glaxo Wellcome's research program

Sep. 1, 1999

5-ht6 receptor function under study at SmithKline Beecham

Aug. 31, 1999

Novel BK channel modulators for stroke reported by Bristol-Myers Squibb

Aug. 31, 1999

AHP investigates oxazole derivatives with potential in treating various CNS disorders

Aug. 31, 1999

Novel emopamil binding site inhibitors synthesized and evaluated at AstraZeneca

Aug. 31, 1999

New IGT compound shows promise in stroke therapy

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...